331 related articles for article (PubMed ID: 7646560)
1. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of mammalian lanosterol 14 alpha-demethylase by RS-21607 in vitro and in vivo.
Swinney DC; So OY; Watson DM; Berry PW; Webb AS; Kertesz DJ; Shelton EJ; Burton PM; Walker KA
Biochemistry; 1994 Apr; 33(15):4702-13. PubMed ID: 8161528
[TBL] [Abstract][Full Text] [Related]
3. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
Qin W; Infante J; Wang SR; Infante R
Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis.
Trzaskos JM; Magolda RL; Favata MF; Fischer RT; Johnson PR; Chen HW; Ko SS; Leonard DA; Gaylor JL
J Biol Chem; 1993 Oct; 268(30):22591-9. PubMed ID: 7693673
[TBL] [Abstract][Full Text] [Related]
5. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
Amin D; Gustafson SK; Weinacht JM; Cornell SA; Neuenschwander K; Kosmider B; Scotese AC; Regan JR; Perrone MH
Pharmacology; 1993; 46(1):13-22. PubMed ID: 8434028
[TBL] [Abstract][Full Text] [Related]
6. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets.
Himber J; Missano B; Rudling M; Hennes U; Kempen HJ
J Lipid Res; 1995 Jul; 36(7):1567-85. PubMed ID: 7595080
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside).
Harwood HJ; Chandler CE; Pellarin LD; Bangerter FW; Wilkins RW; Long CA; Cosgrove PG; Malinow MR; Marzetta CA; Pettini JL
J Lipid Res; 1993 Mar; 34(3):377-95. PubMed ID: 8468523
[TBL] [Abstract][Full Text] [Related]
8. SK&F 97426-A a more potent bile acid sequestrant and hypocholesterolaemic agent than cholestyramine in the hamster.
Benson GM; Alston DR; Bond BC; Gee AN; Glen A; Haynes C; Hickey DM; Iqbal S; Jackson B; Jaxa-Chamiec AA
Atherosclerosis; 1993 Jun; 101(1):51-60. PubMed ID: 8216502
[TBL] [Abstract][Full Text] [Related]
9. Effect of taurine on cholesterol metabolism in hamsters: up-regulation of low density lipoprotein (LDL) receptor by taurine.
Murakami S; Kondo Y; Toda Y; Kitajima H; Kameo K; Sakono M; Fukuda N
Life Sci; 2002 Apr; 70(20):2355-66. PubMed ID: 12150200
[TBL] [Abstract][Full Text] [Related]
10. Increased cellular triglyceride levels in human monocytic and rat smooth muscle cells after lovastatin.
Hrboticky N; Becker A; Kruse HJ; Weber PC
Biochim Biophys Acta; 1997 Nov; 1349(3):211-21. PubMed ID: 9434135
[TBL] [Abstract][Full Text] [Related]
11. Ro 48-8.071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin.
Morand OH; Aebi JD; Dehmlow H; Ji YH; Gains N; Lengsfeld H; Himber J
J Lipid Res; 1997 Feb; 38(2):373-90. PubMed ID: 9162756
[TBL] [Abstract][Full Text] [Related]
12. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells.
Hidaka Y; Hotta H; Nagata Y; Iwasawa Y; Horie M; Kamei T
J Biol Chem; 1991 Jul; 266(20):13171-7. PubMed ID: 1649182
[TBL] [Abstract][Full Text] [Related]
13. Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition properties.
Trzaskos JM; Ko SS; Magolda RL; Favata MF; Fischer RT; Stam SH; Johnson PR; Gaylor JL
Biochemistry; 1995 Aug; 34(30):9670-6. PubMed ID: 7626636
[TBL] [Abstract][Full Text] [Related]
14. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Berkhout TA; Simon HM; Patel DD; Bentzen C; Niesor E; Jackson B; Suckling KE
J Biol Chem; 1996 Jun; 271(24):14376-82. PubMed ID: 8662919
[TBL] [Abstract][Full Text] [Related]
15. Dietary fatty acids differentially modulate messenger RNA abundance of low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and microsomal triglyceride transfer protein in Golden-Syrian hamsters.
Dorfman SE; Lichtenstein AH
Metabolism; 2006 May; 55(5):635-41. PubMed ID: 16631440
[TBL] [Abstract][Full Text] [Related]
16. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
17. Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis.
Frye LL; Leonard DA
Crit Rev Biochem Mol Biol; 1999; 34(2):123-40. PubMed ID: 10333389
[TBL] [Abstract][Full Text] [Related]
18. Effects of LY295427, a low-density lipoprotein (LDL) receptor up-regulator, on LDL receptor gene transcription and cholesterol metabolism in normal and hypercholesterolemic hamsters.
Bensch WR; Gadski RA; Bean JS; Beavers LS; Schmidt RJ; Perry DN; Murphy AT; McClure DB; Eacho PI; Breau AP; Archer RA; Kauffman RF
J Pharmacol Exp Ther; 1999 Apr; 289(1):85-92. PubMed ID: 10086991
[TBL] [Abstract][Full Text] [Related]
19. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of mammalian lanosterol 14 alpha-demethylase: a possible strategy for cholesterol lowering.
Walker KA; Kertesz DJ; Rotstein DM; Swinney DC; Berry PW; So OY; Webb AS; Watson DM; Mak AY; Burton PM
J Med Chem; 1993 Jul; 36(15):2235-7. PubMed ID: 8340925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
